Related Experiment Video
Updated: Jun 14, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Molecular Mechanisms and Pathophysiology of Myocardial Disease: Insights from Pediatric Inflammatory Multisystem
María Teresa Viadero1,2, María Jesús Caldeiro2, Natalia Fernández-Suarez1,2
1Pediatric Cardiology, Division of Pediatrics, University Hospital "Marqués de Valdecilla", University of Cantabria, Avda. Valdecilla s/n, 39008 Santander, Spain.
Insights
Multisystem inflammatory syndrome in children (MIS-C) can cause heart problems. Elevated ferritin and neutrophil-to-lymphocyte ratio (NLR) may indicate ventricular dysfunction in MIS-C patients.
Area of Science:
- Pediatric Cardiology
- Immunology
- Molecular Pathophysiology
Background:
- Multisystem inflammatory syndrome in children (MIS-C), or pediatric inflammatory multisystem syndrome (PIMS), poses challenges in pediatric cardiology.
- Its complex molecular pathophysiology requires further investigation, particularly concerning myocardial involvement.
Purpose of the Study:
- To investigate molecular contributors to myocardial dysfunction in MIS-C.
- To identify potential prognostic indicators for ventricular dysfunction in pediatric patients.
Main Methods:
- Retrospective analysis of 15 MIS-C cases managed at a tertiary care center.
- Evaluation of cytokine storms, hyperinflammation markers, and hypercoagulable states.
- Analysis of ferritin, NT-ProBNP, troponin, and neutrophil-to-lymphocyte ratio (NLR) in relation to ventricular dysfunction.
Main Results:
- Transient myocardial involvement occurred in 46.6% of patients, with full recovery.
- Elevated ferritin, NT-ProBNP, and troponin levels correlated with ventricular dysfunction.
- Higher NLR was observed in patients with ventricular dysfunction, suggesting prognostic value.
- No coronary artery aneurysms were detected.
Conclusions:
- Early, standardized interventions are crucial for mitigating severe outcomes in MIS-C.
- NLR and ferritin show promise as early indicators for identifying high-risk MIS-C patients with potential cardiac involvement.
- Understanding molecular mechanisms aids in managing MIS-C-related myocardial dysfunction.
Abstract:
Multisystem inflammatory syndrome in children (MIS-C), also known as pediatric inflammatory multisystem syndrome (PIMS), presents significant challenges in pediatric cardiology, due to its complex molecular pathophysiology. In this retrospective analysis of 15 cases that were managed at a single tertiary care center, we investigated the molecular contributors to myocardial dysfunction, including cytokine storms, hyperinflammation markers, and hypercoagulable states. Transient myocardial involvement was identified in 46.6% of patients, with complete recovery achieved within 2-4 weeks following treatment. Ferritin, NT-ProBNP, and troponin levels were significantly elevated in patients with ventricular dysfunction compared to those without. The neutrophil-to-lymphocyte ratio (NLR), which was previously identified as a severity marker in acute COVID-19, was also significantly higher in patients with ventricular dysfunction, suggesting its potential as a prognostic indicator in MIS-C. Notably, no coronary artery aneurysms were detected in the cohort. These findings underscore the importance of early, standardized therapeutic interventions in mitigating severe outcomes, and they provide valuable insights into the molecular mechanisms driving myocardial dysfunction in MIS-C. Incorporating NLR and ferritin into the initial diagnostic workup may improve the early triage and identification of high-risk MIS-C patients.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Pneumonia II: Pathophysiology
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
